Literature DB >> 11164467

Reduced IFN-gamma production in elderly people following in vitro stimulation with influenza vaccine and endotoxin.

Q Ouyang1, G Cicek, R G Westendorp, H J Cools, R J van der Klis, E J Remarque.   

Abstract

Cytokine interferon gamma (IFN-gamma) is pivotal in the defence against viruses and intracellular pathogens and an age-related decreased IFN-gamma production may explain the increased infectious disease morbidity and mortality in the elderly. Therefore, we performed a series of clinical experiments evaluating the influence of age and health status on IFN-gamma production following in vitro stimulation with influenza vaccine or endotoxin. Both healthy and frail elderly people produced significantly lower amounts of IFN-gamma following ex vivo stimulation with influenza vaccine or endotoxin. We conclude that ageing is accompanied by a decreased capacity to produce IFN-gamma. This may explain the increased incidence and case-fatality caused by viruses and intracellular pathogens in the elderly.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11164467     DOI: 10.1016/s0047-6374(00)00204-9

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  13 in total

1.  Is ageing associated with a shift in the balance between Type 1 and Type 2 cytokines in humans?

Authors:  M Sandmand; H Bruunsgaard; K Kemp; K Andersen-Ranberg; A N Pedersen; P Skinhøj; B K Pedersen
Journal:  Clin Exp Immunol       Date:  2002-01       Impact factor: 4.330

Review 2.  Cancer vaccines in old age.

Authors:  Claudia Gravekamp
Journal:  Exp Gerontol       Date:  2007-01-02       Impact factor: 4.032

3.  Year-and-a-half old, dried Echinacea roots retain cytokine-modulating capabilities in an in vitro human older adult model of influenza vaccination.

Authors:  David S Senchina; Lankun Wu; Gina N Flinn; Del N Konopka; Joe-Ann McCoy; Mark P Widrlechner; Mark P Widrelechner; Eve Syrkin Wurtele; Marian L Kohut
Journal:  Planta Med       Date:  2006-10-04       Impact factor: 3.352

4.  In vivo and in vitro antiviral effects of berberine on influenza virus.

Authors:  Ying Wu; Ji-qian Li; Ye-ji Kim; Jun Wu; Qian Wang; Yu Hao
Journal:  Chin J Integr Med       Date:  2011-06-10       Impact factor: 1.978

Review 5.  The impact of aging on cancer vaccination.

Authors:  Claudia Gravekamp
Journal:  Curr Opin Immunol       Date:  2011-07-18       Impact factor: 7.486

6.  Age-related differences in cell-specific cytokine production by acutely ill Malawian patients.

Authors:  J N Pettiford; J Jason; O C Nwanyanwu; L K Archibald; P N Kazembe; H Dobbie; W R Jarvis
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

7.  Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection.

Authors:  Masako Unoshima; Hideo Iwasaka; Junko Eto; Yoshiko Takita-Sonoda; Takayuki Noguchi; Akira Nishizono
Journal:  Antimicrob Agents Chemother       Date:  2003-09       Impact factor: 5.191

8.  Cytokine response to vitamin E supplementation is dependent on pre-supplementation cytokine levels.

Authors:  Sarah E Belisle; Lynette S Leka; Gerard E Dallal; Paul F Jacques; Javier Delgado-Lista; Jose M Ordovas; Simin Nikbin Meydani
Journal:  Biofactors       Date:  2008       Impact factor: 6.113

Review 9.  The importance of the age factor in cancer vaccination at older age.

Authors:  Claudia Gravekamp
Journal:  Cancer Immunol Immunother       Date:  2009-03-04       Impact factor: 6.968

10.  Improved hepatitis C treatment response in younger patients: findings from the UK HCV National Register cohort study.

Authors:  H E Harris; A Costella; G Amirthalingam; G Alexander; M E B Ramsay; N Andrews
Journal:  Epidemiol Infect       Date:  2011-11-29       Impact factor: 2.451

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.